Apollo Hospitals announced impressive third-quarter earnings. Net profit surged 35% year-on-year to Rs 502 crore. Revenue grew 17% to Rs 6,477 crore. All business segments showed strong growth. The company continues to invest in advanced clinical capabilities. Citi maintains a Buy rating with a target price of Rs 9,600.
Apollo Hospitals shares in focus after Q3 net profit jumps 35%. Should you buy, sell or hold?
📅 Published: February 11, 2026 |
📂 Category: Uncategorized